The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pierce Christopher since 2020.
This trader's CIK number is 1824631.
At the time of last reporting, Pierce Christopher was the EVP and Chief of Business Oper of Prelude Therapeutics Inc. (stock ticker symbol PRLD).
Also see all insider trading activities at Prelude Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | PRLD | 0 | $0 | 18,028 | $745,600 | 17,000 | $218,450 |
| 2020 | PRLD | 3,750 | $71,250 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-09-02 | PRLD | Sale | 17,000 | 41.44 | 704,412 |
| 2021-09-02 | PRLD | Option Ex | 17,000 | 12.85 | 218,450 |
| 2021-04-08 | PRLD | Sale | 200 | 40.00 | 8,000 |
| 2021-04-07 | PRLD | Sale | 828 | 40.08 | 33,188 |
| 2020-09-29 | PRLD | Buy | 3,750 | 19.00 | 71,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pierce Christopher (EVP and Chief of Business Oper of Prelude Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.